Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Scorpius Holdings Inc SCPX

Healthcare Biotechnology
Scorpius Holdings, Inc., formerly NightHawk Biosciences, Inc., is an integrated contract development and manufacturing company. The Company is focused on advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio... see more

Recent & Breaking News (NYSEAM:SCPX)

Heat Biologics' Announces Planned Investor and Media Livestream Event to Discuss Latest Developments

GlobeNewswire April 14, 2022

Heat Biologics Unveils Enhanced Allogeneic Cell Manufacturing Process

GlobeNewswire March 25, 2022

Heat Biologics Announces Appointment of Greg Burel, Former Director of the Strategic National Stockpile, to its Biothreat Advisory Board and as Senior Advisor to the Company

GlobeNewswire March 23, 2022

Heat Biologics Provides Year-End 2021 Business Update

GlobeNewswire March 14, 2022

Heat Biologics Announces Planned Transfer to the NYSE American

GlobeNewswire February 2, 2022

Elusys Therapeutics Finalizes HHS Contract to Deliver ANTHIM®, Its Treatment for Inhalation Anthrax, to the U.S. Department of Health and Human Services

GlobeNewswire January 31, 2022

Heat Biologics Announces New PTX-35 Preclinical Data in Organ Transplantation and Provides Update on HS-110

GlobeNewswire January 12, 2022

Investor Alert: The M&A Class Action Firm Announces an Investigation of the Merger

PR Newswire December 23, 2021

Heat Biologics Announces Planned Acquisition of Elusys Therapeutics

GlobeNewswire December 21, 2021

Heat Biologics Unveils RapidVax®, A Novel Cellular Vaccine Platform Targeting Known and Unknown Emerging Biological Threats

GlobeNewswire November 30, 2021

Heat Biologics Provides Third Quarter 2021 Business Update

GlobeNewswire November 10, 2021

Heat Biologics Appoints Paul Tebbey as Senior Vice President of Product Development and Portfolio Strategy

GlobeNewswire October 6, 2021

Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th

GlobeNewswire September 15, 2021

Heat Biologics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

GlobeNewswire September 9, 2021

Heat Biologics to Provide Corporate Update

GlobeNewswire August 30, 2021

Heat Biologics Unveils Skunkworx Bio, New Drug Discovery Subsidiary

GlobeNewswire August 26, 2021

Heat Biologics Announces Addition of Former US Senator Mark Pryor to Biothreat Advisory Board

GlobeNewswire August 23, 2021

Heat Biologics Announces New Additions to Biothreat Advisory Board

GlobeNewswire August 19, 2021

Heat Biologics Announces Formation of Biothreat Advisory Board

GlobeNewswire August 18, 2021

Heat Biologics Provides Second Quarter 2021 Business Update

GlobeNewswire August 11, 2021